Clinical trials
Esophageal Neoplasms trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
| Completed | 14 |
| Active, not recruiting | 6 |
| Terminated | 6 |
| Unknown status | 5 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 5 |
| University of Padova | 4 |
| IRCCS San Raffaele | 3 |
| Novartis Pharmaceuticals | 3 |
| AstraZeneca | 2 |
| Revolution Medicines, Inc. | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Amgen | 1 |
| Azienda USL Reggio Emilia - IRCCS | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Neoplasms | 48 |
| Stomach Neoplasms | 21 |
| Colorectal Neoplasms | 12 |
| Endometrial Neoplasms | 11 |
| Pancreatic Neoplasms | 11 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Colonic Neoplasms | 10 |
| Ovarian Neoplasms | 10 |
| Lung Neoplasms | 7 |
| Neoplasms | 7 |
Trials
Showing 51 to 48 of 48. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.